id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-E-3341-0013,FDA,FDA-2016-E-3341,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-05-31T04:00:00Z,2022,5,2022-05-31T04:00:00Z,,2022-05-31T14:53:02Z,,0,0,0900006483cc293f